NSVAX | SSGSX | NSVAX / SSGSX | |
Total Expense Ratio | 0.96 | 1.26 | 76% |
Annual Report Gross Expense Ratio | 1.11 | 1.26 | 88% |
Fund Existence | 23 years | 26 years | - |
Gain YTD | -11.057 | -8.400 | 132% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 781M | 5.52B | 14% |
Annual Yield % from dividends | 1.87 | 0.52 | 357% |
Returns for 1 year | -23.45 | -8.36 | 281% |
Returns for 3 years | -19.31 | -3.90 | 495% |
Returns for 5 years | 12.24 | 21.72 | 56% |
Returns for 10 years | -27.55 | 7.10 | -388% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSMEX | 58.64 | -0.47 | -0.80% |
Fidelity Select Medical Tech and Devcs | |||
LSVVX | 13.73 | -0.13 | -0.94% |
LSV Conservative Value Equity | |||
VTSMX | 142.86 | -1.69 | -1.17% |
Vanguard Total Stock Mkt Idx Inv | |||
KLCKX | 13.60 | -0.17 | -1.23% |
Federated Hermes Kaufmann Large Cap R | |||
CMJIX | 41.41 | -0.63 | -1.50% |
Calvert US Mid Cap Core Rspnb Idx I |